Navigation Links
Meeting highlights the role of molecular imaging biomarkers in clinical research and therapeutics
Date:10/1/2009

Reston, Va.SNM is collaborating with the International Partnership for Critical Markers of Disease (CMOD) during CMOD's 7th Annual Biomarkers and Surrogate Endpoints Symposium, Bethesda North Marriott Hotel and Conference Center, Bethesda, Md., Oct. 19󈞁, 2009. The joint session, co-hosted by SNM and CMOD, will be held on Wednesday, Oct. 21, from 12:30 p.m. to 4:15 p.m.

"We are pleased to further extend our collaboration with the International Partnership for Critical Markers of Disease by holding this joint session on molecular imaging biomarkers in clinical research," said Michael Graham, PhD, MD, SNM president and director of nuclear medicine at the University of Iowa Carver College of Medicine. "We have established a vital scientific partnership to promote the expanded use and validation of molecular imaging biomarkers for clinical trials. Improved availability and performance of molecular imaging biomarkers will facilitate the development of safe and effective therapeutic drugs and ultimately enhance the delivery of personalized medicine."

"Our common interest in accelerating scientific research and therapeutic drug development by creating novel and advanced biomarkers to promote optimal health care today is a model for others to follow," said Therese Heinonen, DVM, executive director and co-founder of the International Partnership for Critical Markers of Disease and associate director of scientific affairs, Montreal Heart Institute Coordinating Center. "SNM and CMOD share the vision of expanding the use of these biomarkers in a standardized clinical research environment where providing high-quality, cost-effective patient care is the ultimate goal."

Peter Libby (co-founder of CMOD and Mallinckrodt Professor of Medicine at Harvard Medical School and chief of cardiovascular medicine at Brigham and Women's Hospital) will moderate the special afternoon session with Michael Graham. Don Black, general manager of molecular imaging at GE Healthcare's Medical Diagnostics, and Alexander J.B. McEwan, MD, chair of the department of oncology at the University of Alberta, Canada, will present perspectives on standardizing molecular imaging clinical trials, with an emphasis on the challenges of developing molecular imaging agents and statistical considerations in trial design. The second panel, led by Dan Skovronsky, founder and CEO of Avid Pharmaceuticals, and Patricia Cole, executive director of Imagepace at Medpace, Inc., will discuss the potential role of molecular imaging biomarkers in therapeutic development in both oncology and neurologytwo areas of significant interest to clinicians, researchers and industry. The session concludes with presentations focused on challenges and opportunities for using molecular imaging biomarkers in clinical research.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. Pelosi and Hoyer Remarks at Press Availability Following Leadership Meeting
2. 2009 American Association of Pharmaceutical Scientists Annual Meeting and Exposition
3. American Society of Plastic Surgeons hosts 78th annual meeting
4. American Society Of Plastic Surgeons Hosts 78th Annual Meeting
5. American Heart Association Meeting Report: High-Sugar Diet Increases Mens Blood Pressure; Gout Drug Protective
6. Data Released at an International Stem Cell Meeting Highlights Effectiveness of New Patient Education System Developed to Support Federal and State Guidelines on Cord Blood Education
7. Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics (TCT) Meeting
8. SpectraScience Announces Results of Annual Shareholder Meeting
9. Maternal/child health focus of African Science Academies meeting in Ghana Nov. 9-11
10. Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting
11. Dean MacCarter, Ph.D. Addressed Differentiation of Responder vs Non-Responder CRT Status with Low Level Exercise at HFSA13th Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... "FCPX editors ... customizable inside of Final Cut Pro X," said Christina Austin - CEO of Pixel ... style. Final Cut Pro X users can now reveal the media of ...
(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... ANDOVER, Mass. and SAN CLEMENTE, Calif. ... California -based mobile pulmonary function testing company, is now ... portable PFT devices developed by ndd Medical Technologies , Inc. ... PFT testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ... CA , can get any needed testing done in the ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
Breaking Medicine Technology: